tetano
Editor, Senior Moderator
Curr Opin Virol
. 2020 Nov 27;44:191-202.
doi: 10.1016/j.coviro.2020.10.005. Online ahead of print.
Reverse genetics for influenza B viruses and recent advances in vaccine development
Stivalis Cardenas-Garcia[SUP] 1 [/SUP], C Joaquin Caceres[SUP] 2 [/SUP], Daniela Rajao[SUP] 2 [/SUP], Daniel R Perez[SUP] 3 [/SUP]
Affiliations
Abstract
Influenza B virus is a respiratory pathogen that affects more severely the pediatric and elderly populations. There are two lineages of influenza B virus that seem to have differential predilection for age groups. Both lineages can co-circulate during the influenza season however one is usually more prominent than the other depending on the season. There are no defined indicators to predict which lineage will dominate in any given season. In recent years, the addition of viruses from both lineages to the seasonal influenza vaccine formulation has improved vaccine protection, although quadrivalent vaccines are not available worldwide. Reverse genetics has facilitated advancements in the field of vaccine development against influenza B virus. Different strategies have been explored showing promising results that could potentially lead to the development broadly protective influenza B virus vaccines.
. 2020 Nov 27;44:191-202.
doi: 10.1016/j.coviro.2020.10.005. Online ahead of print.
Reverse genetics for influenza B viruses and recent advances in vaccine development
Stivalis Cardenas-Garcia[SUP] 1 [/SUP], C Joaquin Caceres[SUP] 2 [/SUP], Daniela Rajao[SUP] 2 [/SUP], Daniel R Perez[SUP] 3 [/SUP]
Affiliations
- PMID: 33254031
- DOI: 10.1016/j.coviro.2020.10.005
Abstract
Influenza B virus is a respiratory pathogen that affects more severely the pediatric and elderly populations. There are two lineages of influenza B virus that seem to have differential predilection for age groups. Both lineages can co-circulate during the influenza season however one is usually more prominent than the other depending on the season. There are no defined indicators to predict which lineage will dominate in any given season. In recent years, the addition of viruses from both lineages to the seasonal influenza vaccine formulation has improved vaccine protection, although quadrivalent vaccines are not available worldwide. Reverse genetics has facilitated advancements in the field of vaccine development against influenza B virus. Different strategies have been explored showing promising results that could potentially lead to the development broadly protective influenza B virus vaccines.